Results 281 to 290 of about 14,337,199 (401)
High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
The Lancet, 2015 Anoop S. V. Shah, A. Anand, Y. Sandoval, K. Lee, Stephen W. Smith, P. Adamson, A. Chapman, Timothy Langdon, D. Sandeman, Amar Vaswani, F. Strachan, A. Ferry, A. Stirzaker, Alan Reid, A. Gray, P. Collinson, D. McAllister, F. Apple, D. Newby, N. Mills +19 moresemanticscholar +1 more sourceClinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer
European Journal of Heart Failure, EarlyView.Cardiac wasting‐associated cardiomyopathy in cancer patients. E/e', early diastolic filling velocity (E) over mitral annulus early diastolic tissue velocity (e'); GLS, global longitudinal strain; LV, left ventricular; LVEF, left ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion.Markus S. Anker, Muhammad Shahzeb Khan, Anja Nikolski, Jan Porthun, Muhammad Sameer Arshad, Sara Hadzibegovic, Alessia Lena, Lucie Kretzler, Jonathan L. Hella, Marco Witkowski, Kathrin Rieger, Johann Ahn, Dominik P. Modest, Ulrich Keller, Lars Bullinger, Matthias Totzeck, Amir A. Mahabadi, Tienush Rassaf, Nikolaus Buchmann, Philipp Attanasio, Tanja Zeller, Mahir Karakas, Carlo G. Tocchetti, Ursula Wilkenshoff, John G. F. Cleland, Stephan von Haehling, Javed Butler, Ulf Landmesser +27 morewiley +1 more sourceMedication adherence in patients with acutely decompensated heart failure: A cross‐sectional study in the emergency department (ADHF‐ED)
European Journal of Heart Failure, EarlyView.The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).Michael Kunz, Juel Maalouli Schaar, Katharina R. Welker, Lucas Lauder, Felix Götzinger, Ingrid Kindermann, Martin Schulz, Michael Böhm, Markus R. Meyer, Felix Mahfoud +9 morewiley +1 more sourceHigh-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy. [PDF]
Circ Heart FailDe Michieli L, Sinigiani G, Guida G, Saturi G, Sena G, Capovilla TM, Cantone A, Cianca A, Lupi A, Porcari A, Tini G, Vergaro G, Cappelli F, Albertini R, Bianco M, Mussinelli R, Serenelli M, Musumeci B, Perlini S, Merlo M, Longhi S, Sinagra G, Perazzolo Marra M, Iliceto S, Jaffe AS, Palladini G, Cipriani A, Milani P. +27 moreeuropepmc +1 more sourcePrognostic significance of somatic mutations in myeloid cells of men with chronic heart failure – interaction between loss of Y chromosome and clonal haematopoiesis
European Journal of Heart Failure, EarlyView.Abstract Aims
Age‐associated clonal haematopoiesis of indeterminate potential (CHIP) has been linked to increased incidence and worse prognosis of chronic heart failure (CHF). CHIP arises from somatic mutations in haematopoietic stem and progenitor cells. Mosaic loss of Y chromosome (LOY), the most common somatic mutation in male blood cells, increases Sebastian Cremer, Moritz von Scheidt, Klara Kirschbaum, Lukas Tombor, Silvia Mas‐Peiro, Wesley Abplanalp, Tina Rasper, Akshay Ware, Andrin Schuff, Alexander Berkowitsch, Johannes Krefting, David Leistner, Heribert Schunkert, Thimoteus Speer, Stefanie Dimmeler, Andreas Michael Zeiher +15 morewiley +1 more sourceCardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
Journal of Thrombosis and Haemostasis, 2015 Y. Benhamou, P. Böelle, P. Böelle, B. Baudin, B. Baudin, S. Ederhy, J. Gras, L. Galicier, É. Azoulay, F. Provôt, É. Maury, F. Pène, J. Mira, A. Wynckel, C. Presne, P. Poullin, J. Halimi, Yahsou Delmas, T. Kanouni, A. Séguin, C. Mousson, A. Servais, D. Bordessoule, P. Pérez, M. Hamidou, A. Cohen, A. Veyradier, P. Coppo +27 moresemanticscholar +1 more sourceRandomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial
European Journal of Heart Failure, EarlyView.EMPower the heArt of patients with TermInal Cancer using Cardiac medicines (EMPATICC). eGFR, estomated glomerular filtration rate; EP, endpoint; FCM, ferric carboxymaltose; LVEF, left ventricular ejection fraction; N‐terminal pro‐B‐type natriuretic peptide; PGA, patient global assessment; PoC, proof of concept; QoL, quality of life; UICC, Union for ...Markus S. Anker, Amir A. Mahabadi, Matthias Totzeck, Mitra Tewes, Raluca Mincu, Muhammad Shahzeb Khan, Javed Butler, Ulrich Keller, Johann Ahn, Lars Bullinger, Dominik P. Modest, Ulf Landmesser, Lorenz H. Lehmann, Sven Bercker, Ulrich Laufs, Michael Böhm, Bela Merkely, Monika Diek, Tim Heise, Martin Hellmich, Marius Placzek, Tim Friede, Stefan D. Anker, Tienush Rassaf +23 morewiley +1 more source